ea0016oc1.3 | Neuroendocrinology and pituitary | ECE2008
van der Klaauw Agatha
, Bax Jeroen
, Stokkel Marcel
, Bleeker Gabe
, Roelfsema Ferdinand
, Smit Johannes
, Romijn Johannes
, Pereira Alberto
Growth hormone deficiency (GHD) can occur after treatment for acromegaly. It is unclear whether treatment with recombinant human growth hormone (rhGH) in these patients is beneficial. Patients were randomized to either 1 year of rhGH replacement (n=10) or placebo followed by rhGH replacement for 1 year (delayed rhGH treatment, n=6). Sixteen patients (8 men, mean age 56 years) with GHD after treatment for acromegaly were studied. Study parameters were assessed at ...